BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mori T, Okamoto S, Matsuoka S, Yajima T, Wakui M, Watanabe R, Ishida A, Iwao Y, Mukai M, Hibi T, Ikeda Y. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:765-769. [PMID: 10745263 DOI: 10.1038/sj.bmt.1702227] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Szer J, Durrant S, Schwarer AP, Bradstock KF, Gibson J, Arthur C, To LB, Hughes T, Raunow H. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation: Oral ganciclovir after BMT. Internal Medicine Journal 2004;34:98-101. [DOI: 10.1111/j.1444-0903.2004.00550.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
2 Sellar RS, Peggs KS. The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation. Cytotherapy 2012;14:391-400. [DOI: 10.3109/14653249.2012.662769] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
3 Takahata M, Hashino S, Nishio M, Sugita J, Shigematsu A, Onozawa M, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T. Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration. Transpl Infect Dis 2015;17:810-5. [PMID: 26354293 DOI: 10.1111/tid.12456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
4 Choi S, Lee D, Choi J, Yoo J, Kim Y, Park SH, Park S, Min C, Lee S, Kim H, Kim D, Lee J, Min W, Shin W, Kim C. Risk-Adapted Preemptive Therapy for Cytomegalovirus Disease after Allogeneic Stem Cell Transplantation: A Single-Center Experience in Korea. International Journal of Hematology 2005;81:69-74. [DOI: 10.1532/ijh97.a30402] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
5 Garrigue I, Doussau A, Asselineau J, Bricout H, Couzi L, Rio C, Merville P, Fleury H, Lafon ME, Thiébaut R. Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients. J Clin Microbiol 2008;46:493-8. [PMID: 18057128 DOI: 10.1128/JCM.01499-07] [Cited by in Crossref: 42] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
6 Kanda Y, Mineishi S, Saito T, Saito A, Ohnishi M, Niiya H, Chizuka A, Nakai K, Takeuchi T, Matsubara H, Makimoto A, Tanosaki R, Kunitoh H, Tobinai K, Takaue Y. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation: . Transplantation 2002;73:568-72. [DOI: 10.1097/00007890-200202270-00015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
7 Eiz-Vesper B, Maecker-Kolhoff B, Blasczyk R. Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry. Front Immunol 2012;3:410. [PMID: 23372567 DOI: 10.3389/fimmu.2012.00410] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vusirikala M, Wolff SN, Stein RS, Brandt SJ, Morgan DS, Greer JP, Schuening FG, Dummer JS, Goodman SA. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis. Bone Marrow Transplant 2001;28:265-70. [PMID: 11535994 DOI: 10.1038/sj.bmt.1703129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kimberlin DW. Antiviral Therapies in Children: Has Their Time Arrived? Pediatric Clinics of North America 2005;52:837-67. [DOI: 10.1016/j.pcl.2005.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mori T, Aisa Y, Nakazato T, Ikeda Y, Okamoto S. Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2005;81:439-40. [PMID: 16158829 DOI: 10.1532/ijh97.05036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A. Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2019;25:587-93. [PMID: 30359733 DOI: 10.1016/j.bbmt.2018.10.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yoon KH, Fong KY, Tambyah PA. Fatal cytomegalovirus infection in two patients with systemic lupus erythematosus undergoing intensive immunosuppressive therapy: role for cytomegalovirus vigilance and prophylaxis? J Clin Rheumatol 2002;8:217-22. [PMID: 17041367 DOI: 10.1097/00124743-200208000-00011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
14 Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am 2011;25:151-69. [PMID: 21236396 DOI: 10.1016/j.hoc.2010.11.011] [Cited by in Crossref: 235] [Cited by in F6Publishing: 200] [Article Influence: 21.4] [Reference Citation Analysis]
15 Wang JY, Chang YL, Lee LN, Chen JH, Tang JL, Yang PC, Lee YC. Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy. Ann Thorac Surg 2004;78:267-72. [PMID: 15223441 DOI: 10.1016/j.athoracsur.2004.03.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
16 Mcgavin JK, Goa KL. Ganciclovir: An Update of its Use in the Prevention of Cytomegalovirus Infection and Disease in Transplant Recipients. Drugs 2001;61:1153-83. [DOI: 10.2165/00003495-200161080-00016] [Cited by in Crossref: 98] [Cited by in F6Publishing: 78] [Article Influence: 4.7] [Reference Citation Analysis]
17 Karigane D, Takaya S, Seki Y, Mastumoto Y, Onose A, Kosakai A, Sugaya N, Mori T. Cytomegalovirus enteritis in immunocompetent subjects: A case report and review of the literature. Journal of Infection and Chemotherapy 2014;20:325-9. [DOI: 10.1016/j.jiac.2013.12.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
18 Mori T, Aisa Y, Nakazato T, Yamazaki R, Shimizu T, Mihara A, Yamane A, Ikeda Y, Okamoto S. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies. Transplant Proc 2007;39:1615-9. [PMID: 17580201 DOI: 10.1016/j.transproceed.2006.12.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Suzuki H, Kato J, Kuriyama M, Hiraoka S, Kuwaki K, Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010; 16(10): 1245-1251 [PMID: 20222169 DOI: 10.3748/wjg.v16.i10.1245] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
20 Junghanss C, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Chauncey T, McSweeney PA, Little MT, Corey L, Storb R. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 2002;99:1978-85. [PMID: 11877269 DOI: 10.1182/blood.v99.6.1978] [Cited by in Crossref: 184] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
21 Cho BS, Yahng SA, Kim JH, Yoon JH, Shin SH, Lee SE, Choi SM, Lee DG, Eom KS, Park G, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy. Ann Hematol 2013;92:497-504. [PMID: 23180439 DOI: 10.1007/s00277-012-1632-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
22 Ksouri H, Eljed H, Greco A, Lakhal A, Torjman L, Abdelkefi A, Othmen TB, Ladeb S, Slim A, Zouari B, Abdeladhim A, Hassen AB. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation. Transplant Infect Dis 2007;9:16-21. [DOI: 10.1111/j.1399-3062.2006.00171.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
23 Leruez-Ville M, Ouachée M, Delarue R, Sauget AS, Blanche S, Buzyn A, Rouzioux C. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 2003;41:2040-6. [PMID: 12734246 DOI: 10.1128/JCM.41.5.2040-2046.2003] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
24 Kim T, Lee HJ, Kim SM, Jung JH, Shin S, Kim YH, Sung H, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH, Han DJ. Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant. Korean J Intern Med 2020;35:438-48. [PMID: 29865778 DOI: 10.3904/kjim.2017.318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 2002;29:599-606. [DOI: 10.1038/sj.bmt.1703513] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
26 McDonald GB, Sarmiento JI, Rees-Lui G, Myerson D. Cytomegalovirus hepatitis after bone marrow transplantation: An autopsy study with clinical, histologic and laboratory correlates. J Viral Hepat 2019;26:1344-50. [PMID: 31315152 DOI: 10.1111/jvh.13176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Sousa H, Boutolleau D, Ribeiro J, Teixeira AL, Pinho Vaz C, Campilho F, Branca R, Campos A Jr, Baldaque I, Medeiros R. Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review. Biol Blood Marrow Transplant 2014;20:1958-67. [PMID: 25139217 DOI: 10.1016/j.bbmt.2014.08.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
28 Fuji S, Kapp M, Grigoleit GU, Einsele H. Adoptive immunotherapy with virus-specific T cells. Best Practice & Research Clinical Haematology 2011;24:413-9. [DOI: 10.1016/j.beha.2011.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
29 Gratama J, Cornelissen J. Potential clinical utility of monitoring cytomegalovirus-specific T lymphocytes in allogeneic stem cell transplantation. Clinical and Applied Immunology Reviews 2001;2:17-32. [DOI: 10.1016/s1529-1049(01)00038-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Boeckh M, Nichols W, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biology of Blood and Marrow Transplantation 2003;9:543-58. [DOI: 10.1016/s1083-8791(03)00287-8] [Cited by in Crossref: 319] [Cited by in F6Publishing: 97] [Article Influence: 16.8] [Reference Citation Analysis]
31 Tsai WP, Chen MH, Lee MH, Yu KH, Wu MW, Liou LB. Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int 2012;32:2901-8. [PMID: 21898057 DOI: 10.1007/s00296-011-2131-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
32 Hamada Y, Nagata N, Shimbo T, Igari T, Nakashima R, Asayama N, Nishimura S, Yazaki H, Teruya K, Gatanaga H. Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients. AIDS Patient Care STDS. 2013;27:387-391. [PMID: 23799239 DOI: 10.1089/apc.2013.0115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Choi S, Lee D, Choi J, Yoo J, Kim Y, Park SH, Min C, Lee S, Kim H, Kim D, Lee J, Min W, Shin W, Kim C. Risk-Adapted Preemptive Therapy for Cytomegalovirus Disease after Allogeneic Stem Cell Transplantation: A Single-Center Experience in Korea. Int J Hematol 2006;83:277-8. [DOI: 10.1007/bf02985486] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
34 Takenaka K, Nagafuji K, Takase K, Kamimura T, Mori Y, Ito Y, Nishi Y, Henzan H, Kato K, Harada N, Eto T, Miyamoto T, Teshima T, Akashi K. Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2012;96:94-100. [DOI: 10.1007/s12185-012-1087-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
35 Hazar V, Kansoy S, Küpesiz A, Aksoylar S, Kantar M, Yeşilipek A. High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation. Bone Marrow Transplant 2004;33:931-5. [DOI: 10.1038/sj.bmt.1704463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
36 Kanda Y, Mineishi S, Saito T, Seo S, Saito A, Suenaga K, Ohnishi M, Niiya H, Nakai K, Takeuchi T, Kawahigashi N, Shoji N, Ogasawara T, Tanosaki R, Kobayashi Y, Tobinai K, Kami M, Mori S, Suzuki R, Kunitoh H, Takaue Y. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan. Bone Marrow Transplant 2001;27:437-44. [DOI: 10.1038/sj.bmt.1702805] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 4.1] [Reference Citation Analysis]
37 Edelmann A, Eichenlaub U, Lepek S, Krüger DH, Hofmann J. Performance of the MagNA Pure 96 system for cytomegalovirus nucleic acid amplification testing in clinical samples. J Clin Microbiol 2013;51:1600-1. [PMID: 23467597 DOI: 10.1128/JCM.03289-12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Mori T, Okamoto S, Watanabe R, Yamazaki R, Tsukada Y, Nagayama H, Ishida A, Ikeda Y. Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection. Bone Marrow Transplant. 2002;29:1005-1006. [PMID: 12098071 DOI: 10.1038/sj.bmt.1703588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
39 Machado C, Menezes R, Macedo M, Mendes A, Vilas Boas L, Castelli J, Dulley F, Pannuti C. Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT. Bone Marrow Transplant 2001;28:1053-9. [DOI: 10.1038/sj.bmt.1703282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
40 Matthes-Martin S, Lion T, Aberle SW, Fritsch G, Lawitschka A, Bittner B, Frommlet F, Gadner H, Peters C. Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality. Bone Marrow Transplant 2003;31:803-8. [PMID: 12732888 DOI: 10.1038/sj.bmt.1703927] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
41 Mori T, Mori S, Kanda Y, Yakushiji K, Mineishi S, Takaue Y, Gondo H, Harada M, Sakamaki H, Yajima T, Iwao Y, Hibi T, Okamoto S. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:431-434. [PMID: 14676775 DOI: 10.1038/sj.bmt.1704369] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 4.4] [Reference Citation Analysis]
42 Kampmann SE, Schindele B, Apelt L, Bührer C, Garten L, Weizsaecker K, Krüger DH, Ehlers B, Hofmann J. Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection. Med Microbiol Immunol 2011;200:109-13. [DOI: 10.1007/s00430-010-0181-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
43 Jung J, Lee HJ, Kim SM, Kang YA, Lee YS, Chong YP, Sung H, Lee SO, Choi SH, Kim YS, Woo JH, Lee JH, Lee JH, Lee KH, Kim SH. Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients. J Clin Virol 2017;87:5-11. [PMID: 27984766 DOI: 10.1016/j.jcv.2016.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
44 Bonon SH, Menoni SM, Rossi CL, De Souza CA, Vigorito AC, Costa DB, Costa SC. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients. J Infect 2005;50:130-7. [PMID: 15667914 DOI: 10.1016/j.jinf.2003.11.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
45 Kimberlin DW. Antiviral Agents. Principles and Practice of Pediatric Infectious Diseases. Elsevier; 2018. pp. 1551-1567.e6. [DOI: 10.1016/b978-0-323-40181-4.00295-4] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Claas EC, Schilham MW, de Brouwer CS, Hubacek P, Echavarria M, Lankester AC, van Tol MJ, Kroes AC. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005;43:1738-44. [PMID: 15814994 DOI: 10.1128/JCM.43.4.1738-1744.2005] [Cited by in Crossref: 87] [Cited by in F6Publishing: 26] [Article Influence: 5.1] [Reference Citation Analysis]
47 Iida T, Ikeya K, Watanabe F, Abe J, Maruyama Y, Ohata A, Teruyuki S, Sugimoto K, Hanai H. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus. Inflamm Bowel Dis. 2013;19:1156-1163. [PMID: 23619714 DOI: 10.1097/mib.0b013e31828075ce] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
48 Stockmann C, Roberts JK, Knackstedt ED, Spigarelli MG, Sherwin CM. Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection. Expert Opin Drug Metab Toxicol 2015;11:205-19. [PMID: 25428442 DOI: 10.1517/17425255.2015.988139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
49 Assogba BD, Choi BH, Rho HM. Transcriptional activation of the promoter of human cytomegalovirus immediate early gene (CMV-IE) by the hepatitis B viral X protein (HBx) through the NF-kappaB site. Virus Res. 2002;84:171-179. [PMID: 11900849 DOI: 10.1016/s0168-1702(01)00445-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Vij R, Khoury H, Brown R, Goodnough LT, Devine SM, Blum W, Adkins D, Dipersio JF. Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation. Bone Marrow Transplant 2003;32:703-7. [DOI: 10.1038/sj.bmt.1704216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hakki M, Ljungman P. Cytomegalovirus Infection After Stem Cell Transplantation. In: Ljungman P, Snydman D, Boeckh M, editors. Transplant Infections. Cham: Springer International Publishing; 2016. pp. 417-40. [DOI: 10.1007/978-3-319-28797-3_24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007;102:331-337. [PMID: 17156136 DOI: 10.1111/j.1572-0241.2006.00989.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 136] [Article Influence: 8.8] [Reference Citation Analysis]
53 Ghaffari SH, Obeidi N, Dehghan M, Alimoghaddam K, Gharehbaghian A, Ghavamzadeh A. Monitoring of Cytomegalovirus Reactivation in Bone Marrow Transplant Recipients by Real-time PCR. Pathol Oncol Res 2008;14:399-409. [DOI: 10.1007/s12253-008-9030-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
54 Moon S, Sung H, Kim M, Lee S, Choi S, Kim Y, Woo J, Kim S. Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia. Transpl Infect Dis 2012;14:192-7. [DOI: 10.1111/j.1399-3062.2011.00703.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
55 Ladanyi A, Sher AC, Herlitz A, Bergsrud DE, Kraeft S, Kepros J, Mcdaid G, Ferguson D, Landry ML, Chen LB. Automated detection of immunofluorescently labeled cytomegalovirus-infected cells in isolated peripheral blood leukocytes using decision tree analysis. Cytometry 2004;58A:147-56. [DOI: 10.1002/cyto.a.20016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
56 Hong SI, Kim T, Park SY, Jung J, Lee JY, Chong YP, Sung H, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Sensitivity of the Cytomegalovirus Antigenemia Assay to Diagnose Cytomegalovirus Retinitis. Infect Chemother 2016;48:302-8. [PMID: 27883376 DOI: 10.3947/ic.2016.48.4.302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Boriskin Y, Fuller K, Powles R, Vipond I, Rice P, Booth J, Caul E, Butcher P. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. Journal of Clinical Virology 2002;24:13-23. [DOI: 10.1016/s1386-6532(01)00209-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Fujimoto D, Matsushima A, Nagao M, Takakura S, Ichiyama S. Risk factors associated with elevated blood cytomegalovirus pp65 antigen levels in patients with autoimmune diseases. Modern Rheumatology 2014;23:345-50. [DOI: 10.3109/s10165-012-0651-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
59 Kim SH, Lee HJ, Kim SM, Jung JH, Shin S, Kim YH, Sung H, Lee SO, Choi SH, Kim YS, Woo JH, Han DJ. Diagnostic Usefulness of Cytomegalovirus (CMV)-Specific T Cell Immunity in Predicting CMV Infection after Kidney Transplantation: A Pilot Proof-of-Concept Study. Infect Chemother 2015;47:105-10. [PMID: 26157588 DOI: 10.3947/ic.2015.47.2.105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
60 Yoshihara R, Komai T, Shoda H, Fujio K. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases. Int J Rheum Dis 2020;23:1534-40. [PMID: 33051990 DOI: 10.1111/1756-185X.13990] [Reference Citation Analysis]
61 Gentile G, Picardi A, Capobianchi A, Spagnoli A, Cudillo L, Dentamaro T, Tendas A, Cupelli L, Ciotti M, Volpi A, Amadori S, Martino P, de Fabritiis P. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation. BMC Infect Dis 2006;6:167. [PMID: 17118205 DOI: 10.1186/1471-2334-6-167] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
62 Kim JY, Hong SY, Park WK, Kim RY, Kim M, Park YG, Kim HJ, Lee S, Lee DG, Park YH. Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation. PLoS One 2020;15:e0238257. [PMID: 32877457 DOI: 10.1371/journal.pone.0238257] [Reference Citation Analysis]
63 Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Semin Pediatr Infect Dis 2002;13:22-30. [PMID: 12118840 DOI: 10.1053/spid.2002.29754] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
64 Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin North Am. 2010;24:319-337. [PMID: 20466273 DOI: 10.1016/j.idc.2010.01.008] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 8.5] [Reference Citation Analysis]
65 Kimberlin DW. Acyclovir derivatives and other new antiviral agents. Seminars in Pediatric Infectious Diseases 2001;12:224-34. [DOI: 10.1053/spid.2001.24097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-saito K, Sakamoto K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Ashizawa M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation. Transpl Infect Dis 2014;16:904-13. [DOI: 10.1111/tid.12304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A. Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation. Transpl Infect Dis 2019;21:e13049. [PMID: 30656802 DOI: 10.1111/tid.13049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Nagata N, Kobayakawa M, Shimbo T, Hoshimoto K, Yada T, Gotoda T, Akiyama J, Oka S, Uemura N. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol 2011; 17(9): 1185-1191 [PMID: 21448424 DOI: 10.3748/wjg.v17.i9.1185] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
69 Solano C, Muñoz I, Gutiérrez A, Farga A, Prósper F, García-Conde J, Navarro D, Gimeno C. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J Clin Microbiol 2001;39:3938-41. [PMID: 11682510 DOI: 10.1128/JCM.39.11.3938-3941.2001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
70 Park SY, Jung JH, Kwon H, Shin S, Kim YH, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH, Han DJ. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study. Transpl Infect Dis 2020;22:e13245. [PMID: 31943590 DOI: 10.1111/tid.13245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
71 Meijer E, Boland GJ, Verdonck LF. Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev 2003;16:647-57. [PMID: 14557291 DOI: 10.1128/CMR.16.4.647-657.2003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
72 Goodgame RW. Viral causes of diarrhea. Gastroenterol Clin North Am 2001;30:779-95. [PMID: 11586557 DOI: 10.1016/s0889-8553(05)70210-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
73 Mori T, Kato J. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation. Int J Hematol 2010;91:588-95. [PMID: 20414753 DOI: 10.1007/s12185-010-0569-x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
74 Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y, Nakazato T, Shimizu T, Ikeda Y, Okamoto S. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant. 2007;13:100-106. [PMID: 17222758 DOI: 10.1016/j.bbmt.2006.09.003] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
75 Mori T, Aisa Y, Shimizu T, Nakazato T, Yamazaki R, Ikeda Y, Okamoto S. Prevention of cytomegalovirus infection by valaciclovir after allogeneic bone marrow transplantation from an unrelated donor. Int J Hematol 2006;83:266-70. [PMID: 16720561 DOI: 10.1532/IJH97.E0523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
76 Mori T, Okamoto S, Watanabe R, Yajima T, Iwao Y, Yamazaki R, Nakazato T, Sato N, Iguchi T, Nagayama H, Takayama N, Hibi T, Ikeda Y. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;29:777-82. [DOI: 10.1038/sj.bmt.1703542] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]